- About Us
- Our BioBank Platform Technology
- Our Drug Programmes
- Contact us
Our specialist approach to drug discovery and development in the respiratory disease area is validated by the collaborations we have already formed. Our partners have been particularly attracted to Synairgen because of our advanced in vitro human cell models of disease.
If your company might benefit from Synairgen’s specialist drug discovery and development capabilities, please contact us at firstname.lastname@example.org
We are looking to in-license or partner programmes which have potential utility in asthma, COPD or other lung diseases. In particular we would like to apply our BioBank model platform and clinical competence to new opportunities.